Trial Profile
A Drug-Drug Interaction Study Between Danoprevir/Low-dose Ritonavir and Cyclosporine, a Potent Inhibitor of OATP, in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Danoprevir (Primary) ; Ciclosporin; Ritonavir
- Indications Hepatitis C; HIV infections
- Focus Pharmacokinetics
- Sponsors Roche
- 16 Apr 2012 Actual patient number 18 added as reported by ClinicalTrials.gov.
- 16 Apr 2012 Actual end date 1 Apr 2012 added as reported by ClinicalTrials.gov.
- 16 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.